title: Should single agents be standard therapy for urothelial tract tumors?
authors.affiliation: Memorial Sloan-Kettering Cancer Center, New York.
authors.forename: H I
authors.initials: HI
authors.lastname: Scher
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage* / Q000627:therapeutic use; D002985:Clinical Protocols; D004848:Epithelium / Q000473:pathology; D006801:Humans; D014571:Urologic Neoplasms / Q000188:drug therapy*